[Retracted] The Significance of Apolipoprotein-A in the Long-Term Death of Patients with STEMI

Table 2

Comparative analysis of the two categories of laboratory results.

Variable	High-Apo-A group	Low-Apo-A group	value
Number of cases	143	57	—
WBC count (10^9/L)	11.30 ± 4.35	12.68 ± 7.28	0.184
Hemoglobin (g/L)	138.52 ± 16.48	135.85 ± 22.20	0.351
Neutrophil count (10^9/L)	9.17 ± 4.57	9.33 ± 4.48	0.819
Apolipoprotein-A (g/L)	0.99 ± 0.13	0.70 ± 0.72	0.001
Apolipoprotein -B/A	0.95 ± 0.32	1.12 ± 0.43	0.003
Triglycerides (mmol/L)	1.66 ± 0.66	1.84 ± 3.24	0.621
High-density lipoprotein (mmol/L)	1.12 ± 0.28	0.86 ± 0.14	0.001
Serum creatinine (umol/L)	75.77 ± 19.47	77.32 ± 32.04	0.888
Serum uric acid (umol/L)	377.33 ± 97.62	368.47 ± 110.35	0.121
D-dimer (ug/mL)	0.81 ± 1.44	1.56 ± 5.56	0.094
High-sensitivity C-reactive protein (mg/L)	8.56 ± 16.52	21.52 ± 34.97	0.001
Troponin I (ng/ml)	33.53 ± 32.84	35.02 ± 33.30	0.773
NT-pro-BNP (Pg/ml)	1509.55 ± 3940.31	1165.89 ± 1701.20	0.528
Hypersensitivity thyrotropin (uIU/ml)	1.28 ± 1.41	1.14 ± 0.65	0.601
Glycated hemoglobin (%)	7.18 ± 1.76	7.24 ± 2.30	0.862
Ejection fraction (%)	58.210 ± 7.82	58.44 ± 7.90	0.859

WBC, white blood cell; NT-pro-BNP, N-terminal pro-B-type natriuretic peptide.